Abstract
Strategies for prevention of venous thromboembolism in orthopaedic patients undergoing major lower limb surgery include pharmacological prophylaxis. Over the last three decades, the search for new safe and effective approaches for the prevention of venous thromboembolism in these patients has continued. Increased understanding of the haemostatic process has led to a clearer appreciation of the mechanisms of action of antithrombotic drugs already in use as well as the identification of new targets for novel drug development. As a result, the development of new anticoagulants has advanced rapidly over recent years. The molecular targets of several novel anticoagulants, and their effectiveness in early Phase II and Phase III trials are reviewed.
Keywords: Anticoagulants, venous thromboembolism, pulmonary embolism, haemostasis, thromboprophylaxis, antithrombotic drugs, prophylaxis, fibrinolytic mechanism, intravascular thrombosis, ticlopidine, vasoconstriction, Von Willebrand factor, serotonin, prostaglandins, factor X, antithrombin, auto-regulation, tissue factor pathway inhibitor (TFPI), Heparin, penta-saccharide, Thrombomodulin, tissue-type plasminogen, urokinase-type plasminogen activator (uPA), plasmin (via alpha2-antiplasmin), hemorhelogy, vascular bifurcations, atheromatous, Virchow's triad, sequelae, Varicose veins, pulmonary emboli, fatal pulmonary emboli, (hirudin), specific factor Xa inhibitors (fondaparinux), oral warfarin sodium, haematophagous organisms, Tifacogin, FVIIai, NAPc2, Fondaparinux, Idraparinux, DX9065a, LY 517717, Razaxaban, Rivaroxaban (BAY59-7939), SSR12517E, SSR123781A, Otamixaben, Apixaban, Ximelagatran, Dabigatran etexilate
Current Vascular Pharmacology
Title: The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
Volume: 9 Issue: 1
Author(s): Elizabeth O. Johnson, Maria Konstandi, George C. Babis, Mara Piagkou and Panayotis N. Soucacos
Affiliation:
Keywords: Anticoagulants, venous thromboembolism, pulmonary embolism, haemostasis, thromboprophylaxis, antithrombotic drugs, prophylaxis, fibrinolytic mechanism, intravascular thrombosis, ticlopidine, vasoconstriction, Von Willebrand factor, serotonin, prostaglandins, factor X, antithrombin, auto-regulation, tissue factor pathway inhibitor (TFPI), Heparin, penta-saccharide, Thrombomodulin, tissue-type plasminogen, urokinase-type plasminogen activator (uPA), plasmin (via alpha2-antiplasmin), hemorhelogy, vascular bifurcations, atheromatous, Virchow's triad, sequelae, Varicose veins, pulmonary emboli, fatal pulmonary emboli, (hirudin), specific factor Xa inhibitors (fondaparinux), oral warfarin sodium, haematophagous organisms, Tifacogin, FVIIai, NAPc2, Fondaparinux, Idraparinux, DX9065a, LY 517717, Razaxaban, Rivaroxaban (BAY59-7939), SSR12517E, SSR123781A, Otamixaben, Apixaban, Ximelagatran, Dabigatran etexilate
Abstract: Strategies for prevention of venous thromboembolism in orthopaedic patients undergoing major lower limb surgery include pharmacological prophylaxis. Over the last three decades, the search for new safe and effective approaches for the prevention of venous thromboembolism in these patients has continued. Increased understanding of the haemostatic process has led to a clearer appreciation of the mechanisms of action of antithrombotic drugs already in use as well as the identification of new targets for novel drug development. As a result, the development of new anticoagulants has advanced rapidly over recent years. The molecular targets of several novel anticoagulants, and their effectiveness in early Phase II and Phase III trials are reviewed.
Export Options
About this article
Cite this article as:
O. Johnson Elizabeth, Konstandi Maria, C. Babis George, Piagkou Mara and N. Soucacos Panayotis, The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery, Current Vascular Pharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157016111793744779
DOI https://dx.doi.org/10.2174/157016111793744779 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Semicarbazide-Sensitive Amine Oxidase: Current Status and Perspectives
Current Medicinal Chemistry Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews Statins and Portal Hypertension: A New Pharmacological Challenge
Current Vascular Pharmacology Pharmacological Agents in the Treatment of Venous Disease: An Update of the Available Evidence
Current Vascular Pharmacology Phytocompounds as Potential Agents to Treat Obesity-Cardiovascular Ailments
Cardiovascular & Hematological Agents in Medicinal Chemistry Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews The Significance of Pain in Chronic Venous Disease and its Medical Treatment
Current Vascular Pharmacology Tissue Engineering Applications and Stem Cell Approaches to the Skin, Nerves and Blood Vessels
Current Stem Cell Research & Therapy Scientific Papers and Patents on Substances with Unproven Effects. Part 2
Recent Patents on Drug Delivery & Formulation L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds
Current Pharmaceutical Biotechnology Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Current Vascular Pharmacology Variations and Abnormalities of Major Thoracic Vascular Structures
Current Medical Imaging On the Sympathetic Innervation of the Human Greater Saphenous Vein: Relevance to Clinical Practice
Current Vascular Pharmacology The Role of MDCT in Craniocervical Junction Pathologies: Pictorial Review
Current Medical Imaging Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures
Current Pharmaceutical Design Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.
Current Alzheimer Research Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology